Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients
NCT04852796
·
clinicaltrials.gov ↗
COMPLETED
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Hematologic Malignancy
Vaccine Response Impaired
Interventions
OTHER:
Patients with hemopathy
Sponsor
Centre Hospitalier de Cornouaille